Policyholder Services
| << Back |
Will my OMIC policy cover me for using Restylane?
On December 12, 2003, Medicis received FDA approval to market Restylane in the United States. In recognition of the filler’s FDA approval status, OMIC will extend coverage to physicians who use Restylane for the correction of facial wrinkles and/or lip augmentation. OMIC also offers a sample Restylane consent form, developed by Dr. John Shore, a member of OMIC’s Underwriting and Risk Management Committees and practicing oculoplastic surgeon.
Click here for sample Consent for Restylane Injection form.
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website
